サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1729411

日本のエピジェネティクス市場レポート：製品、技術、用途、地域別、2025年～2033年

Japan Epigenetics Market Report by Product, Technology, Application, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 121 Pages
納期
5～7営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.37円
日本のエピジェネティクス市場レポート：製品、技術、用途、地域別、2025年～2033年
出版日: 2025年05月01日
発行: IMARC
ページ情報: 英文 121 Pages
納期: 5～7営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

日本のエピジェネティクスの市場規模は2024年に1億6,000万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに4億5,700万米ドルに達し、2025年から2033年にかけて12.4%の成長率（CAGR）を示すと予測しています。がん、糖尿病、心血管疾患などの慢性疾患の症例の増加と、これらの病態を管理するためのエピジェネティック研究と診断への需要の高まりが、主に市場を牽引しています。

本レポートで扱う主な質問

  • 日本のエピジェネティクス市場はこれまでどのように推移し、今後どのように推移するのか？
  • COVID-19が日本のエピジェネティクス市場に与えた影響は？
  • 日本のエピジェネティクス市場の製品別区分は？
  • 日本のエピジェネティクス市場の技術別区分は？
  • 日本のエピジェネティクス市場の用途別区分は？
  • 日本のエピジェネティクス市場のバリューチェーンにおける様々なステージとは？
  • 日本のエピジェネティクスの主な促進要因と課題は何か？
  • 日本のエピジェネティクス市場の構造と主要プレーヤーは？
  • 日本のエピジェネティクス市場における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
  • 市場推定
  • 調査手法

第3章 エグゼクティブサマリー

第4章 日本のエピジェネティクス市場：イントロダクション

  • 概要
  • 市場力学
  • 業界動向
  • 競合情報

第5章 日本のエピジェネティクス市場情勢

  • 過去および現在の市場動向（2019～2024年）
  • 市場予測（2025～2033年）

第6章 日本のエピジェネティクス市場：製品別の内訳

  • 試薬
  • キット
  • 機器
  • 酵素
  • サービス

第7章 日本のエピジェネティクス市場：技術別の内訳

  • DNAメチル化
  • ヒストンのメチル化
  • ヒストンのアセチル化
  • 大きな非コードRNA
  • マイクロRNAの修飾
  • クロマチン構造

第8章 日本のエピジェネティクス市場：用途別の内訳

  • 腫瘍学
  • 非腫瘍学

第9章 日本のエピジェネティクス市場：競合情勢

  • 概要
  • 市場構造
  • 市場企業のポジショニング
  • 主要成功戦略
  • 競合ダッシュボード
  • 企業評価象限

第10章 主要企業のプロファイル

第11章 日本のエピジェネティクス市場：業界分析

  • 促進要因、抑制要因、機会
  • ポーターのファイブフォース分析
  • バリューチェーン分析

第12章 付録

目次
Product Code: SR112025A18151

Japan epigenetics market size reached USD 160.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 457.0 Million by 2033, exhibiting a growth rate (CAGR) of 12.4% during 2025-2033. The escalating cases of chronic diseases such as cancer, diabetes, and cardiovascular diseases, coupled with the rising demand for epigenetic research and diagnostics to manage these conditions, are primarily driving the market.

Epigenetics refers to changes in gene expression that occur without alterations to the underlying DNA sequence. It involves modifications to the structure of DNA and its associated proteins, which can turn genes on or off, influencing an organism's traits and development. Epigenetic mechanisms include DNA methylation, where methyl groups are added to DNA, and histone modifications, which alter the packaging of DNA in the cell nucleus. These modifications can be influenced by environmental factors, lifestyle choices, and even experiences across generations. Epigenetics plays a crucial role in various biological processes, such as embryonic development, cellular differentiation, and the regulation of gene activity. It also has implications for health and disease, as epigenetic changes can contribute to the development of diseases like cancer, cardiovascular disease, and mental health disorders. Understanding epigenetics has the potential to shed light on the interplay between genetics and the environment, providing insights into gene regulations and their impact on health and well-being.

Japan Epigenetics Market Trends:

The epigenetics market in Japan has witnessed remarkable growth in recent years, primarily owing to its potential to revolutionize understanding of gene regulation and its implications in various fields. Firstly, advancements in technology, such as next-generation sequencing and high-throughput assays, have propelled the epigenetics market forward. These tools enable researchers to analyze DNA methylation, histone modifications, and non-coding RNA expression at an unprecedented scale and accuracy. Furthermore, the rising prevalence of complex diseases, including cancer, neurological disorders, and metabolic conditions, has driven the demand for epigenetic studies. Epigenetic alterations have been linked to the development and progression of these diseases, creating a pressing need for targeted therapies and diagnostic tools. Additionally, the growing awareness of the role of epigenetics in personalized medicine has sparked interest among pharmaceutical companies, further stimulating the market. Moreover, government and private investments in epigenetics research have surged, fostering innovation and collaboration among academic institutions and biotechnology firms. This financial support has accelerated the development of epigenetic drugs and diagnostic solutions. Lastly, the increasing adoption of epigenetic testing in clinical settings, coupled with a growing aging population, is expected to drive the epigenetics market in Japan during the forecast period.

Japan Epigenetics Market Segmentation:

Product Insights:

  • Reagents
  • Kits
    • Chip Sequencing Kit
    • Whole Genomic Amplification Kit
    • Bisulfite Conversion Kit
    • RNA Sequencing Kit
    • Others
  • Instruments
  • Enzymes
  • Services

Technology Insights:

  • DNA Methylation
  • Histone Methylation
  • Histone Acetylation
  • Large Non-Coding RNA
  • MicroRNA Modification
  • Chromatin Structures

Application Insights:

  • Oncology
    • Solid Tumors
    • Liquid Tumors
  • Non-Oncology
    • Inflammatory Diseases
    • Metabolic Diseases
    • Infectious Diseases
    • Cardiovascular Diseases
    • Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan epigenetics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan epigenetics market?
  • What is the breakup of the Japan epigenetics market on the basis of product?
  • What is the breakup of the Japan epigenetics market on the basis of technology?
  • What is the breakup of the Japan epigenetics market on the basis of application?
  • What are the various stages in the value chain of the Japan epigenetics market?
  • What are the key driving factors and challenges in the Japan epigenetics?
  • What is the structure of the Japan epigenetics market and who are the key players?
  • What is the degree of competition in the Japan epigenetics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Epigenetics Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Epigenetics Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan Epigenetics Market - Breakup by Product

  • 6.1 Reagents
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Forecast (2025-2033)
  • 6.2 Kits
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Segmentation
      • 6.2.3.1 Chip Sequencing Kit
      • 6.2.3.2 Whole Genomic Amplification Kit
      • 6.2.3.3 Bisulfite Conversion Kit
      • 6.2.3.4 RNA Sequencing Kit
      • 6.2.3.5 Others
    • 6.2.4 Market Forecast (2025-2033)
  • 6.3 Instruments
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2019-2024)
    • 6.3.3 Market Forecast (2025-2033)
  • 6.4 Enzymes
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2019-2024)
    • 6.4.3 Market Forecast (2025-2033)
  • 6.5 Services
    • 6.5.1 Overview
    • 6.5.2 Historical and Current Market Trends (2019-2024)
    • 6.5.3 Market Forecast (2025-2033)

7 Japan Epigenetics Market - Breakup by Technology

  • 7.1 DNA Methylation
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 Histone Methylation
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Forecast (2025-2033)
  • 7.3 Histone Acetylation
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2019-2024)
    • 7.3.3 Market Forecast (2025-2033)
  • 7.4 Large Non-Coding RNA
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2019-2024)
    • 7.4.3 Market Forecast (2025-2033)
  • 7.5 MicroRNA Modification
    • 7.5.1 Overview
    • 7.5.2 Historical and Current Market Trends (2019-2024)
    • 7.5.3 Market Forecast (2025-2033)
  • 7.6 Chromatin Structures
    • 7.6.1 Overview
    • 7.6.2 Historical and Current Market Trends (2019-2024)
    • 7.6.3 Market Forecast (2025-2033)

8 Japan Epigenetics Market - Breakup by Application

  • 8.1 Oncology
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2019-2024)
    • 8.1.3 Market Segmentation
      • 8.1.3.1 Solid Tumors
      • 8.1.3.2 Liquid Tumors
    • 8.1.4 Market Forecast (2025-2033)
  • 8.2 non-oncology
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2019-2024)
    • 8.2.3 Market Segmentation
      • 8.2.3.1 Inflammatory Diseases
      • 8.2.3.2 Metabolic Diseases
      • 8.2.3.3 Infectious Diseases
      • 8.2.3.4 cardiovascular diseases
      • 8.2.3.5 Others
    • 8.2.4 Market Forecast (2025-2033)

9 Japan Epigenetics Market - Competitive Landscape

  • 9.1 Overview
  • 9.2 Market Structure
  • 9.3 Market Player Positioning
  • 9.4 Top Winning Strategies
  • 9.5 Competitive Dashboard
  • 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

  • 10.1 Company A
    • 10.1.1 Business Overview
    • 10.1.2 Product Portfolio
    • 10.1.3 Business Strategies
    • 10.1.4 SWOT Analysis
    • 10.1.5 Major News and Events
  • 10.2 Company B
    • 10.2.1 Business Overview
    • 10.2.2 Product Portfolio
    • 10.2.3 Business Strategies
    • 10.2.4 SWOT Analysis
    • 10.2.5 Major News and Events
  • 10.3 Company C
    • 10.3.1 Business Overview
    • 10.3.2 Product Portfolio
    • 10.3.3 Business Strategies
    • 10.3.4 SWOT Analysis
    • 10.3.5 Major News and Events
  • 10.4 Company D
    • 10.4.1 Business Overview
    • 10.4.2 Product Portfolio
    • 10.4.3 Business Strategies
    • 10.4.4 SWOT Analysis
    • 10.4.5 Major News and Events
  • 10.5 Company E
    • 10.5.1 Business Overview
    • 10.5.2 Product Portfolio
    • 10.5.3 Business Strategies
    • 10.5.4 SWOT Analysis
    • 10.5.5 Major News and Events

11 Japan Epigenetics Market - Industry Analysis

  • 11.1 Drivers, Restraints and Opportunities
    • 11.1.1 Overview
    • 11.1.2 Drivers
    • 11.1.3 Restraints
    • 11.1.4 Opportunities
  • 11.2 Porters Five Forces Analysis
    • 11.2.1 Overview
    • 11.2.2 Bargaining Power of Buyers
    • 11.2.3 Bargaining Power of Suppliers
    • 11.2.4 Degree of Competition
    • 11.2.5 Threat of New Entrants
    • 11.2.6 Threat of Substitutes
  • 11.3 Value Chain Analysis

12 Appendix